dimecres, 12 de març del 2014

Report: Medtech mergers, FDA approvals tank in 'unlucky' 2013




Market pressures weigh heavy on medtech in 2013, with M&A activity down 16% and FDA approvals down 44% year-over-year, but at least it wasn't the decade's worst period.





Medtech mergers, FDA approvals slide in 'unlucky' 2013

Last year was a tough one for the medical device industry, with acquisition activity down, M&A dollars cut in half and FDA approvals slashed, but at least it wasn't the worst year that medtech has faced in the last decade – 2009 still holds that title.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1ga5M6z

Cap comentari:

Publica un comentari a l'entrada